As codirector of the Drug Research Unit (DRU), I bring nearly 20 years experience in analytical development and focus on development of novel methods for some of the most critical but understudied drugs in the world, such as drugs for malaria. My research interest is in optimizing these methods so we can quantitate drugs as close to the site of pharmacological action as is possible with the overarching goal of treating patients with the best drug regimens. Administratively, I oversee analytical work at the DRU and core activities that support our UCSF collaborators for a variety of research projects and facilitate identifying new collaborations.